Meeting
2017 Genitourinary Cancers Symposium
The association of androgen deprivation therapy and anxiety among 78,000 patients with localized prostate cancer patients.
Authors
Kathryn T Dinh
University of Washington, Seattle, WA
Kathryn T Dinh , Gally Reznor , Vinayak Muralidhar , Neil E. Martin , Peter F. Orio , Quoc-Dien Trinh , Paul L. Nguyen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer,Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 35, 2017 (suppl 6S; abstract 19)
DOI
10.1200/JCO.2017.35.6_suppl.19
Abstract #
19
Poster Bd #
B6
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
Longitudinal screening for depression and anxiety in prostate cancer (PC) and association with disease and treatment factors.
First Author: Risa Liang Wong
Poster
2020 ASCO Virtual Scientific Program
Depression, anxiety, and patterns of mental health care among men with prostate cancer on androgen deprivation therapy (ADT).
First Author: Phoebe A. Tsao
Poster
2024 ASCO Genitourinary Cancers Symposium
Weight variation during androgen deprivation therapy in patients with localized prostate cancer: Data from two prospective randomized trials.
First Author: Abdenour Nabid
Poster
2024 ASCO Genitourinary Cancers Symposium
Neoadjuvant darolutamide plus androgen deprivation therapy for high-risk/very high-risk localized prostate cancer: A multicenter, open-labeled, single-arm phase II trial.
First Author: Junlong Zhuang